newsAmgen and Cytokinetics announce the first presentation of data from Phase 2 ATOMIC-AHF study of Omecamtiv Mecarbil3 September 2013 | By AmgenFirst trial to evaluate cardiac myosin activator in patients with acute heart failure presented at ESC Congress 2013...
newsAmgen and Cytokinetics announce expansion of license for Omecamtiv Mecarbil12 June 2013 | By AmgenAmgen and Cytokinetics announced an expansion of their strategic collaboration...